FDA Investigates COVID Vaccine Link to 10 Child Fatalities
- FDA Director Calls for Tougher Vaccine Guidelines, Cites Potential Risks
- Vinay Prasad, director of the FDA's Center for Biologics Evaluation and Research, has issued a memo calling for tougher guidelines for COVID-19 vaccine approvals.
- * Myocarditis Risk: The memo details that the deaths were linked to myocarditis, a potentially serious condition that can lead to blood clots and heart attack.
Here’s a summary of the article, focusing on the key points:
FDA Director Calls for Tougher Vaccine Guidelines, Cites Potential Risks
Dr. Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research, has issued a memo calling for tougher guidelines for COVID-19 vaccine approvals. The memo highlights a finding that 10 children died after receiving COVID-19 vaccines, with the cause of death being myocarditis (inflammation of the heart muscle).
Key Points:
* Myocarditis Risk: The memo details that the deaths were linked to myocarditis, a potentially serious condition that can lead to blood clots and heart attack.
* Risk Comparison: While mRNA COVID-19 vaccines do carry a small increased risk of myocarditis, especially in young males, studies show the risk is significantly higher from contracting COVID-19 itself. A 2022 meta-analysis found the risk of myocarditis was over seven times higher in the infection group then the vaccination group,and a 2024 study found it to be 20 times higher.
* Internal FDA Debate: Prasad stated he is open to debate on vaccine policies and suggested staff members who disagree with his direction should resign.
* Timing: This suggestion comes before a meeting of advisors to the Department of Health and Human Services (HHS) to discuss potential changes to the childhood vaccine schedule.
* Previous Claims: robert F. Kennedy Jr. made similar claims about the risk of myocarditis from COVID-19 vaccines in 2021.
The article presents a complex issue, acknowledging the potential risks of the vaccine while emphasizing that the risk of myocarditis is substantially greater from COVID-19 infection.